ClinVar Miner

Submissions for variant NM_014874.3(MFN2):c.775C>T (p.Arg259Cys) (rs587777875)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000197364 SCV000251712 likely pathogenic not provided 2017-11-28 criteria provided, single submitter clinical testing A variant that is likely pathogenic has been identified in the MFN2 gene. The R259C variant has been previously reported in multiple individuals with CMT2A (Sitarz et al., 2012; Drew et al., 2015; Leonardi et al., 2015). TheR259C variant is not observed in large population cohorts (Lek et al., 2016). The R259C variant is anon-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Additionally, missense variants in a nearby residue (S263P) and at the sameresidue (R259L/H) have been reported in the Human Gene Mutation Database in association with MFN2-related neuropathy (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.
Athena Diagnostics Inc RCV000197364 SCV000614094 likely pathogenic not provided 2017-02-16 criteria provided, single submitter clinical testing
Invitae RCV000653884 SCV000775774 pathogenic Charcot-Marie-Tooth disease, type 2 2020-08-14 criteria provided, single submitter clinical testing This sequence change replaces arginine with cysteine at codon 259 of the MFN2 protein (p.Arg259Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals affected with autosomal dominant Charcot-Marie-Tooth disease (PMID: 22492563, 24957169, 25802885, 25957633). ClinVar contains an entry for this variant (Variation ID: 155730). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Different missense substitutions at this codon (p.Arg259Leu and p.Arg259His), including one determined to be likely pathogenic, have been reported in individuals affected with Charcot-Marie-Tooth disease (PMID: 19350291, 24627108, 24863639). This suggests that the arginine residue is critical for MFN2 protein function and that other missense substitutions at this position may also be pathogenic. For these reasons, this variant has been classified as Pathogenic.
Molecular Genetics Laboratory,London Health Sciences Centre RCV000789066 SCV001336795 likely pathogenic Charcot-Marie-Tooth disease criteria provided, single submitter clinical testing
Northcott Neuroscience Laboratory, ANZAC Research Institute RCV000143799 SCV000188692 pathogenic Charcot-Marie-Tooth disease, type 2A2A no assertion criteria provided not provided Converted during submission to Pathogenic.
Inherited Neuropathy Consortium RCV000789066 SCV000928415 uncertain significance Charcot-Marie-Tooth disease no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.